| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/07/2007 | WO2007098548A1 A molecule and chimeric molecules thereof |
| 09/07/2007 | WO2007098547A1 A molecule and chimeric molecules thereof |
| 09/07/2007 | CA2644595A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 09/07/2007 | CA2643100A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/07/2007 | CA2638832A1 Chimeric vaccine antigens against the avian influenza virus |
| 09/07/2007 | CA2638830A1 Chimeric vaccine antigens against classical swine fever virus |
| 09/06/2007 | US20070207964 Combined use of a GLP-1 compound and another drug for treating dyslipidemia |
| 09/06/2007 | US20070207521 Novel phospholipases and uses thereof |
| 09/06/2007 | US20070207506 G-protein coupled receptor and DNA sequences thereof |
| 09/06/2007 | US20070207160 Apoptosis inhibitors |
| 09/05/2007 | EP1829895A1 Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies |
| 09/05/2007 | EP1829892A2 Staphylococcus aureus proteins and nucleic acids |
| 09/05/2007 | EP1829891A2 Immunoassays for Anti-HCV Antibodies |
| 09/05/2007 | EP1829551A1 Modified heat shock protein-antigenic peptide complex |
| 09/05/2007 | EP1827492A2 Antibodies directed to gpnmb and uses thereof |
| 09/05/2007 | EP1539802B1 Novel kcnq polypeptides and their uses in the diagnosis of mental disorders |
| 09/05/2007 | EP1410802B1 Cell death inducers for mast cells |
| 09/05/2007 | EP1259541B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/05/2007 | EP1093465B1 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 09/05/2007 | CN100335900C Novel self-assembly molecules |
| 09/04/2007 | US7265208 Autoimmune disease; allergies vaccine |
| 09/04/2007 | US7265203 Human cytokine receptor |
| 09/04/2007 | US7264805 Proteins with a high immunoreactivity and a method for the production thereof |
| 08/30/2007 | WO2007097812A2 Therapeutic anti-her2 antibody fusion polypeptides |
| 08/30/2007 | WO2007095737A1 Combination therapy for the treatment of diabetes comprising an exendin agonist and a gastrin compound |
| 08/30/2007 | US20070202566 Hydrolases, Nucleic Acids Encoding Them And Methods For Making And Using Them |
| 08/30/2007 | US20070202125 Inhibiting rejection of a graft |
| 08/30/2007 | DE60122300T2 Hepatitis b kernprotein fusionsproteine Hepatitis B core protein fusion proteins |
| 08/30/2007 | CA2628253A1 Therapeutic anti-her2 antibody fusion polypeptides |
| 08/29/2007 | EP1826270A1 Method and library for in vitro selection |
| 08/29/2007 | EP1824979A2 Methods, products and uses involving platelets and/or the vasculature |
| 08/29/2007 | EP1517913B9 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
| 08/29/2007 | EP1165781B1 Protease resistant flint analogs |
| 08/29/2007 | EP1073724B1 Laundry detergent and/or fabric care compositions comprising a modified enzyme |
| 08/29/2007 | EP1009814B1 Human receptor tyrosine kinase, kdr |
| 08/29/2007 | EP1007653B1 Detection methods comprising the use of polypeptides comprising a coiled-coil and an addition site |
| 08/29/2007 | CN100334215C Antidisense immune and bactericidal function fusion protein hcml gene and its protein |
| 08/29/2007 | CN100334214C Hybrid expression of Neisseria protein |
| 08/29/2007 | CN100334114C Novel fusion protein production and uses |
| 08/29/2007 | CN100334113C Method for enhancing antiseptic peptide stability and its application |
| 08/29/2007 | CN100334112C Interfusion protein of human interleukin 15 and Fe |
| 08/29/2007 | CN100334111C Recombined protein of anti tumour, encoded gene and application |
| 08/28/2007 | US7262276 Two polypeptide domains connected by a polypeptide linker, one is anti-ovarian cancer antibody, or its Fab fragment, single complementarity determining region (CDR) antibody or single chain Fv (scFv) and the other is anti-CD3 antibody, or its Fab fragment, single CDR antibody or scFv |
| 08/28/2007 | US7262275 Graft polymer of polyester and polypeptide; prevent cyclization |
| 08/28/2007 | US7262050 Humanised antibodies |
| 08/28/2007 | US7262042 Alkaline proteases of the subtilisin type |
| 08/28/2007 | US7262014 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 08/28/2007 | US7262005 Methods of protein destabilization and uses thereof |
| 08/28/2007 | US7261897 Fusion proteins of mycobacterium tuberculosis |
| 08/28/2007 | US7261890 Methods for using canine immunoglobulin variable domains and caninized antibodies |
| 08/28/2007 | CA2125763C P40 homodimer of interleukin-12 |
| 08/28/2007 | CA2124460C Production of anti-self antibodies from segment repertoires and displayed on phage |
| 08/24/2007 | CA2568981A1 Integrase-derived hiv-inhibiting agents |
| 08/23/2007 | WO2007094570A1 Self-assembly nano-composites comprising hydrophilic bioactive peptides and hydrophobic materials |
| 08/23/2007 | WO2007062819A3 Multimeric complexes of antigens and an adjuvant |
| 08/23/2007 | WO2007059136A3 Rankl antibody-pth/pthrp chimeric molecules |
| 08/23/2007 | US20070196816 Engineered stimulus-responsive switches |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196369 MHC-peptide complex binding ligands |
| 08/23/2007 | CA2642054A1 Influenza antigens, vaccine compositions, and related methods |
| 08/23/2007 | CA2641342A1 Long-acting polypeptides and methods of producing and administering same |
| 08/23/2007 | CA2638907A1 Rage fusion proteins and methods of use |
| 08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
| 08/22/2007 | EP1820859A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/22/2007 | EP1487868B1 Chimeric delta endotoxin protein of cry1ea and cry1ca |
| 08/22/2007 | EP1124568B1 Polyspecific binding molecules and uses thereof |
| 08/22/2007 | CN101023103A Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide |
| 08/21/2007 | US7259147 treating multiple sclerosisbby administering an inhibitor of JTT-1 antigen activity. |
| 08/21/2007 | US7259137 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases |
| 08/21/2007 | US7258986 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 08/21/2007 | CA2196419C Improvements in or relating to binding proteins for recognition of dna |
| 08/16/2007 | WO2007091907A1 Method of hydrolysis of peptide bond |
| 08/16/2007 | WO2007091178A2 Construction of new variants of dextransucrase dsr-s by genetic engineering |
| 08/16/2007 | WO2007090630A2 Peptide aptamer for neutralizing the binding of platelet antigene specific antibodies and diagnostic and therapeutic applications containing the same |
| 08/16/2007 | WO2007090584A1 Modified coagulation factor vila with extended half-life |
| 08/16/2007 | WO2003080856A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/16/2007 | US20070190049 Use of A33 antigens and JAM-IT |
| 08/16/2007 | CA2639150A1 Construction of new variants of dextransucrase dsr-s by genetic engineering |
| 08/16/2007 | CA2636671A1 Modified coagulation factor vila with extended half-life |
| 08/16/2007 | CA2636632A1 Novel viral vector |
| 08/15/2007 | EP1818062A1 An anti HSP90 antibody |
| 08/15/2007 | EP1636263B1 Pegylated soluble gp130-dimers useful as a medicament |
| 08/15/2007 | EP0981618B1 Anti-apo-2 antibody |
| 08/15/2007 | EP0752874B1 Enhanced virus-mediated dna transfer |
| 08/15/2007 | CN101018808A Compositions and methods for regulation of tumor necrosis factor-alpha |
| 08/15/2007 | CN101016548A Soluble conversion growth factor beta II type receptor/gamma-interferon recombination fusion albumen and preparation thereof |
| 08/15/2007 | CN101016547A Method of preparing ocean double RNA virus MABV recombination albumen and application thereof |
| 08/15/2007 | CN101016340A Fusion polypeptide and use thereof in treatment of tumor and cell growth abnormity correlated disease |
| 08/15/2007 | CN101016339A Dual active protein containing stroma cell derivative factor-1 and immunoglobulin-Fc section, and application thereof |
| 08/14/2007 | US7256267 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 08/14/2007 | US7256253 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 08/14/2007 | US7256034 Inhibitor of cell proliferation and methods of use thereof |
| 08/14/2007 | CA2394572C Fusion protein having enhanced in vivo activity of erythropoietin |
| 08/09/2007 | WO2007088882A1 Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell |
| 08/09/2007 | WO2007020243A3 Vaccine based on virus-neutralizing antibodies |
| 08/09/2007 | WO2007016150A3 Mutated pseudomonas exotoxins with reduced antigenicity |
| 08/09/2007 | US20070184070 Recombinant toxin fragments |
| 08/09/2007 | US20070184064 Chimeric peptide immunogens |
| 08/08/2007 | EP1816201A1 Modified coagulation factor VIIa with extended half-life |
| 08/08/2007 | EP1814905A1 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |